Karin Enell Smith (Former)

1 – 10 of 11

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/b57dbb79-8e87-4f14-877e-049966452cd1?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
2
next »

2025
Mark First-in-human, multicenter, open-label, phase I study of ATOR-1017 (evunzekibart), a 4-1BB antibody, in patients with advanced solid malignancies
Carneiro, Ana ^LU ; Hahn, Amanda ; Ellmark, Peter ^LU ; Enell Smith, Karin ^LU ; Schultz, Lena ; Ambarkhane, Sumeet ; Yachnin, Jeffrey and Ullenhag, Gustav J (2025) In Journal for ImmunoTherapy of Cancer 13.
- Contribution to journal › Article
Mark CD40 agonist mitazalimab with mFOLFIRINOX in untreated metastatic pancreatic cancer : Biomarkers associated with outcomes from OPTIMIZE-1
Van Laethem, Jean-Luc ; Geboes, Karen ; Borbath, Ivan ; Macarulla Mercade, Teresa ; Lambert, Aurélien ; Cassier, Philippe ; Prenen, Hans ; Mitry, Emmanuel ; Blanc, Jean-Frédéric and Pilla, Lorenzo , et al. (2025) In Cell Reports Medicine
- Contribution to journal › Article
2021
Mark The human anti-CD40 agonist antibody mitazalimab (ADC-1013; JNJ-64457107) activates antigen-presenting cells, improves expansion of antigen-specific T cells, and enhances anti-tumor efficacy of a model cancer vaccine in vivo
Deronic, Adnan ^LU ; Nilsson, Anneli ; Thagesson, Mia ; Werchau, Doreen ; Enell Smith, Karin ^LU and Ellmark, Peter ^LU (2021) In Cancer Immunology, Immunotherapy 70(12). p.3629-3642
- Contribution to journal › Article
Mark Rationale and clinical development of CD40 agonistic antibodies for cancer immunotherapy
Enell Smith, Karin ^LU ; Deronic, Adnan ^LU ; Hägerbrand, Karin ^LU ; Norlén, Per ^LU and Ellmark, Peter ^LU (2021) In Expert Opinion on Biological Therapy 21(12). p.1635-1646
- Contribution to journal › Scientific review
2019
Mark The CTLA-4 x OX40 bispecific antibody ATOR-1015 induces anti-tumor effects through tumor-directed immune activation
Kvarnhammar, Anne Månsson ; Veitonmäki, Niina ; Hägerbrand, Karin ^LU ; Dahlman, Anna ^LU ; Smith, Karin Enell ^LU ; Fritzell, Sara ^LU ; Von Schantz, Laura ^LU ; Thagesson, Mia ; Werchau, Doreen and Smedenfors, Kristine , et al. (2019) In Journal for ImmunoTherapy of Cancer 7(1).
- Contribution to journal › Article
2009
Mark Immunizations With IFN gamma Secreting Tumor Cells can Eliminate Fully Established and Invasive Rat Gliomas
Janelidze, Shorena ^LU ; Bexell, Daniel ^LU ; Badn, Wiaam ^LU ; Darabi, Anna ^LU ; Enell Smith, Karin ^LU ; Fritzell, Sara ^LU ; Gunnarsson, Salina ^LU ; Milos, Peter ; Bengzon, Johan ^LU and Salford, Leif ^LU , et al. (2009) In Journal of Immunotherapy 32(6). p.593-601
- Contribution to journal › Article
Mark Immunizations with IFNgamma secreting tumor cells can eliminate fully established and invasive rat gliomas.
Janelidze, Shorena ^LU ; Bexell, Daniel ^LU ; Badn, Wiaam ^LU ; Darabi, Anna ^LU ; Enell Smith, Karin ^LU ; Fritzell, Sara ^LU ; Gunnarsson, Salina ^LU ; Milos, Peter ; Bengzon, Johan ^LU and Salford, Leif ^LU , et al. (2009) In Journal of Immunotherapy 32(6). p.593-601
- Contribution to journal › Article
Mark Cure of established GL261 mouse gliomas after combined immunotherapy with GM-CSF and IFNgamma is mediated by both CD8(+) and CD4(+) T-cells.
Enell Smith, Karin ^LU ; Fritzell, Sara ^LU ; Badn, Wiaam ^LU ; Eberstål, Sofia ^LU ; Janelidze, Shorena ^LU ; Visse, Edward ^LU ; Darabi, Anna ^LU and Siesjö, Peter ^LU (2009) In International Journal of Cancer 124(3). p.630-637
- Contribution to journal › Article
2008
Mark Immunotherapy against malignant brain tumors - of mice and men
Enell Smith, Karin ^LU (2008) In Lund University Faculty of Medicine Doctoral Dissertation Series 2008:56.
- Thesis › Doctoral thesis (compilation)
2007
Mark Postimmunization with IFN-gamma-secreting glioma cells combined with the inducible nitric oxide synthase inhibitor mercaptoethylguanidine prolongs survival of rats with intracerebral tumors
Badn, Wiaam ^LU ; Visse, Edward ^LU ; Darabi, Anna ^LU ; Enell Smith, Karin ^LU ; Salford, Leif ^LU and Siesjö, Peter ^LU (2007) In Journal of Immunology 179(6). p.4231-4238
- Contribution to journal › Article

« previous
1
2
next »